During the past decade, Hyogo Prefectural Amagasaki General Medical Center conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hyogo Prefectural Amagasaki General Medical Center" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Chugai Pharmaceutical" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Prefectural Amagasaki General Medical Center" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hyogo Prefectural Amagasaki General Medical Center" are "Heart Failure" (5 trials), "Macular Edema" (3 trials), "Angina Pectoris" (2 trials), "Atrial Fibrillation" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hyogo Prefectural Amagasaki General Medical Center" in a lesser frequency.

Most popular intervention types in "Hyogo Prefectural Amagasaki General Medical Center" are "Drug" (19 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Placebo" (5 trials), "Aflibercept" (4 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hyogo Prefectural Amagasaki General Medical Center" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Hyogo Prefectural Amagasaki General Medical Center". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hyogo Prefectural Amagasaki General Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hyogo Prefectural Amagasaki General Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".